title: The cost of science : knowledge and ethics in the HIV pre-exposure prophylaxis trials.
abstract: Over the past decade AIDS research has turned toward the use of pharmacology in HIV prevention, including pre-exposure prophylaxis (PrEP): the use of HIV medication as a means of preventing HIV acquisition in those who do not have it. This paper explores the contradictory reasons offered in support of PrEP-to empower women, to provide another risk-reduction option for gay men-as the context for understanding the social meaning of the experimental trials that appear to show that PrEP works in gay men and heterosexual couples but not single women. The PrEP debates reveal the different ideas about "demedicalization" in the earlier gay health and women's health movements and highlight the relationship between health activism and critique of research ethics in the context of a global pharmaceutical market.
authors.affiliation: Sociology and Anthropology and Canada Research Chair in Community, Culture and Health, Simon Fraser University, Burnaby, Canada. ckpatton@sfu.ca
authors.forename: Cindy
authors.initials: C
authors.lastname: Patton
authors.forename: Hye Jin
authors.initials: HJ
authors.lastname: Kim
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003906:Developing Countries; D004812:Epidemiologic Methods; D032984:Ethics, Research; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D040261:Harm Reduction / Q000941:ethics*; D020010:Heterosexuality; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D012306:Risk; D016387:Women's Health
chemical_list: D019380:Anti-HIV Agents